These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33711414)

  • 1. Therapeutic applications of the cancer immunoediting hypothesis.
    Desai R; Coxon AT; Dunn GP
    Semin Cancer Biol; 2022 Jan; 78():63-77. PubMed ID: 33711414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategies for cancer immunotherapy: counter-immunoediting therapy.
    Liu S; Sun Q; Ren X
    J Hematol Oncol; 2023 Apr; 16(1):38. PubMed ID: 37055849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Immunoediting in the Era of Immuno-oncology.
    Gubin MM; Vesely MD
    Clin Cancer Res; 2022 Sep; 28(18):3917-3928. PubMed ID: 35594163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer immunoediting and resistance to T cell-based immunotherapy.
    O'Donnell JS; Teng MWL; Smyth MJ
    Nat Rev Clin Oncol; 2019 Mar; 16(3):151-167. PubMed ID: 30523282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
    Schreiber RD; Old LJ; Smyth MJ
    Science; 2011 Mar; 331(6024):1565-70. PubMed ID: 21436444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.
    Aragon-Sanabria V; Kim GB; Dong C
    Adv Exp Med Biol; 2018; 1092():113-138. PubMed ID: 30368751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
    Vahidian F; Duijf PHG; Safarzadeh E; Derakhshani A; Baghbanzadeh A; Baradaran B
    Immunol Lett; 2019 Apr; 208():19-29. PubMed ID: 30862442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.
    Mittal D; Gubin MM; Schreiber RD; Smyth MJ
    Curr Opin Immunol; 2014 Apr; 27():16-25. PubMed ID: 24531241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
    Wilczyński JR; Nowak M
    Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances of RNA m
    Ma S; Barr T; Yu J
    Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.
    Vesely MD; Schreiber RD
    Ann N Y Acad Sci; 2013 May; 1284(1):1-5. PubMed ID: 23651186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.
    Curigliano G; Criscitiello C; Esposito A; Fumagalli L; Gelao L; Locatelli M; Minchella I; Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S96-9. PubMed ID: 24074802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
    Ariyasu R; Nishikawa H
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and acidosis: immune suppressors and therapeutic targets.
    Damgaci S; Ibrahim-Hashim A; Enriquez-Navas PM; Pilon-Thomas S; Guvenis A; Gillies RJ
    Immunology; 2018 Jul; 154(3):354-362. PubMed ID: 29485185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon α in cancer immunoediting: From elimination to escape.
    Vidal P
    Scand J Immunol; 2020 May; 91(5):e12863. PubMed ID: 31909839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
    Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
    Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The senescence journey in cancer immunoediting.
    Zingoni A; Antonangeli F; Sozzani S; Santoni A; Cippitelli M; Soriani A
    Mol Cancer; 2024 Apr; 23(1):68. PubMed ID: 38561826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concept of immune surveillance against tumors. The first theories.
    Ribatti D
    Oncotarget; 2017 Jan; 8(4):7175-7180. PubMed ID: 27764780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of Neoantigen-Mediated Immunoediting in Cancer Evolution.
    Wu T; Wang G; Wang X; Wang S; Zhao X; Wu C; Ning W; Tao Z; Chen F; Liu XS
    Cancer Res; 2022 Jun; 82(12):2226-2238. PubMed ID: 35486454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.